Craft

Sequana Medical

Stock Price

€1

2024-10-29

Market Capitalization

€40.1 M

2024-10-29

Revenue

€105 K

FY, 2024

Sequana Medical Summary

Company Summary

Overview
Sequana Medical is a medical device company developing implantable pump systems to manage fluid balance within the body. It offers treatment options for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company offers alfapump, a fully implantable, programmable, wirelessly-charged, and battery-powered system for the treatment of refractory ascites.
Type
Public
Status
Active
Founded
2006
HQ
Gent, BE | view all locations
Website
https://www.sequanamedical.com/
Cybersecurity rating
Sectors

Key People

  • Pierre Chauvineau

    Pierre Chauvineau, Chairman of the Board

    • Lies Vanneste, Director Investor Relations

      • Kirsten van Bockstaele

        Kirsten van Bockstaele, Chief Financial Officer

        • Ian Crosbie

          Ian Crosbie, Executive Director, CEO

          LocationsView all

          3 locations detected

          • Gent, Vlaanderen HQ

            Belgium

            Technologiepark-Zwijnaarde 122

          • München, BY

            Germany

            Rundfunkpl. 2

          • Zürich, ZH

            Switzerland

            Technopark, Technoparkstrasse 1

          Sequana Medical Financials

          Summary Financials

          Gross profit (H1, 2025)
          €383.0K
          Net income (H1, 2025)
          (€18.3M)
          Cash (H1, 2025)
          €7.3M
          EBIT (H1, 2025)
          (€8.6M)
          Enterprise value
          $74.2M

          Footer menu